AKT1 and acute kidney injury: Specifically, we confirmed that <i>Ds</i>-Dio alleviates AKI by modulating the PI3K/AKT pathway, resulting in concurrent suppression of NF-κB-mediated inflammation and activation of NRF2-dependent antioxidant responses.